Applied DNA Sciences, Inc. (BNBX)vsBlackstone Group Inc (BX)
BNBX
Applied DNA Sciences, Inc.
$0.16
+5.47%
FINANCIAL SERVICES · Cap: $2.72M
BX
Blackstone Group Inc
$128.28
-0.18%
FINANCIAL SERVICES · Cap: $149.90B
Smart Verdict
WallStSmart Research — data-driven comparison
Blackstone Group Inc generates 739560% more annual revenue ($15.48B vs $2.09M). BX leads profitability with a 22.7% profit margin vs 0.0%. BX appears more attractively valued with a PEG of 1.21. BX earns a higher WallStSmart Score of 75/100 (B+).
BNBX
Hold48
out of 100
Grade: D+
BX
Strong Buy75
out of 100
Grade: B+
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 34.3% year-over-year
Every $100 of equity generates 39 in profit
Strong operational efficiency at 54.4%
Earnings expanding 57.3% YoY
Large-cap with strong market position
Keeps 23 of every $100 in revenue as profit
Revenue surging 28.6% year-over-year
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Weak financial health signals
Moderate valuation
Trading at 11.4x book value
Elevated debt levels
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : BNBX
The strongest argument for BNBX centers on Price/Book, Revenue Growth. Revenue growth of 34.3% demonstrates continued momentum. PEG of 1.27 suggests the stock is reasonably priced for its growth.
Bull Case : BX
The strongest argument for BX centers on Return on Equity, Operating Margin, EPS Growth. Profitability is solid with margins at 22.7% and operating margin at 54.4%. Revenue growth of 28.6% demonstrates continued momentum.
Bear Case : BNBX
The primary concerns for BNBX are EPS Growth, Market Cap, Profit Margin.
Bear Case : BX
The primary concerns for BX are P/E Ratio, Price/Book, Debt/Equity. Debt-to-equity of 1.56 is elevated, increasing financial risk.
Key Dynamics to Monitor
BNBX profiles as a hypergrowth stock while BX is a growth play — different risk/reward profiles.
BX carries more volatility with a beta of 1.56 — expect wider price swings.
BNBX is growing revenue faster at 34.3% — sustainability is the question.
BX generates stronger free cash flow (1.9B), providing more financial flexibility.
Bottom Line
BX scores higher overall (75/100 vs 48/100), backed by strong 22.7% margins and 28.6% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Applied DNA Sciences, Inc.
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company is headquartered in Stony Brook, New York.
Blackstone Group Inc
FINANCIAL SERVICES · ASSET MANAGEMENT · USA
Blackstone Group Inc. is an alternative asset management company specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity strategies and multiple asset classes. The company is headquartered in New York, New York with additional offices across Asia, Europe and North America.
Compare with Other ASSET MANAGEMENT Stocks
Want to dig deeper into these stocks?